Acne Treatment Pads

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Acne Treatment Pads
Generic name: SALICYLIC ACID
Manufacturer: Spa de Soleil
Product type: HUMAN OTC DRUG
SPL set ID: cc0f8f77-1942-22be-e053-2a95a90a3d7f
SPL ID: 50b6e826-3ec8-ee59-e063-6294a90a43eb
Version: 2
Effective date: 2026-04-30
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:19:11

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Acne Treatment Pads	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Spa de Soleil	openfda.manufacturer_name
ndc	package	68062-9004-1	openfda.package_ndc
ndc	product	68062-9004	openfda.product_ndc
ndc11	package	68062900401	derived:openfda.package_ndc
spl id		50b6e826-3ec8-ee59-e063-6294a90a43eb	id
spl set id		cc0f8f77-1942-22be-e053-2a95a90a3d7f	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: For external use only. Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Sensitivity test for new users: Apply product sparingly to one or two small affected areas during the first three days. If no discomfort occurs, follow the steps stated in directions.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.